We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$14.4B
AUM Growth
-$17.7M
Cap. Flow
-$611M
Cap. Flow %
-4.24%
Top 10 Hldgs %
13.47%
Holding
2,887
New
161
Increased
708
Reduced
1,103
Closed
120

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$17.7M
2
AVGO icon
Broadcom
AVGO
+$9.26M
3
WMB icon
Williams Companies
WMB
+$8M
4
KMI icon
Kinder Morgan
KMI
+$7.12M
5
NRG icon
NRG Energy
NRG
+$6.75M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$38M
2
MET icon
MetLife
MET
+$36.4M
3
AAPL icon
Apple
AAPL
+$22.5M
4
CB icon
Chubb
CB
+$20.4M
5
XOM icon
ExxonMobil
XOM
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 12.64%
3 Energy 11.87%
4 Healthcare 11.79%
5 Industrials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TTC icon
2351
Toro Company
TTC
$9.21B
$248K ﹤0.01%
7,796
-164
-2% -$5.23K
FBNK
2352
DELISTED
First Connecticut Bancorp, Inc
FBNK
$248K ﹤0.01%
15,427
– –
ALTO icon
2353
Alto Ingredients
ALTO
$326M
$247K ﹤0.01%
+16,157
New +$224K
CSLT
2354
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$247K ﹤0.01%
+16,244
New +$264K
BBRG
2355
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$247K ﹤0.01%
15,799
– –
NC icon
2356
NACCO Industries
NC
$316M
$245K ﹤0.01%
21,207
– –
NBSE
2357
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$245K ﹤0.01%
+64
New +$241K
ARAV
2358
DELISTED
Aravive, Inc. Common Stock
ARAV
$245K ﹤0.01%
+1,454
New +$251K
ZEN
2359
DELISTED
ZENDESK INC
ZEN
$245K ﹤0.01%
+14,104
New +$236K
AGNC icon
2360
AGNC Investment
AGNC
$13B
$244K ﹤0.01%
10,421
+140
+1% +$3.22K
PETS icon
2361
PetMed Express
PETS
$43.4M
$244K ﹤0.01%
18,117
– –
AUD
2362
DELISTED
Audacy, Inc.
AUD
$244K ﹤0.01%
22,746
– –
FRNK
2363
DELISTED
FRANKLIN FINL CORP VA COM STK (VA)
FRNK
$244K ﹤0.01%
11,252
– –
AORT icon
2364
Artivion
AORT
$1.39B
$243K ﹤0.01%
27,156
– –
TCRT icon
2365
Alaunos Therapeutics
TCRT
$4.86M
$243K ﹤0.01%
402
– –
VSEC icon
2366
VSE Corp
VSEC
$6.48B
$243K ﹤0.01%
6,912
– –
OME
2367
DELISTED
Omega Protein
OME
$243K ﹤0.01%
17,782
– –
NRF
2368
DELISTED
NorthStar Realty Finance Corp.
NRF
$243K ﹤0.01%
7,106
-124,949
-95% -$3.94M
BOOM icon
2369
DMC Global
BOOM
$153M
$242K ﹤0.01%
10,951
– –
ORN icon
2370
Orion Group Holdings
ORN
$392M
$242K ﹤0.01%
22,372
– –
SENEA icon
2371
Seneca Foods Class A
SENEA
$1.31B
$242K ﹤0.01%
7,920
– –
PTX
2372
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$242K ﹤0.01%
+2,698
New +$165K
AR icon
2373
Antero Resources
AR
$11.3B
$241K ﹤0.01%
3,665
+1,893
+107% +$120K
TWIN icon
2374
Twin Disc
TWIN
$349M
$241K ﹤0.01%
7,278
-125
-2% -$3.77K
TTPH
2375
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$241K ﹤0.01%
+894
New +$192K
93 94
95
96 97

Similar funds

GWM
Graybill Wealth Management Elmhurst, Illinois $328M AUM 21.42% 1-Year Est. Return
KSCM
King Street Capital Management New York $328M AUM 0.61% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $328M AUM 25.24% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
ML
Maniro Ltd Nassau $330M AUM
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
PCM
Payne Capital Management New York $331M AUM 19.65% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s Q2 2014 Portfolio in Review

As of Q2 2014, Metropolitan Life Insurance Company (MetLife) held 2,887 positions worth $14.4B, down 0.12% from $14.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $611M in Q2 2014, closing 120 positions and reducing 1,103 holdings. Its most notable exit was Monsanto Co, an estimated $38M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Energy.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $17.1M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2014 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 150,000 shares worth $17.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to Broadcom in Q2 2014, an estimated $9.26M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2014 reduction was Apple, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Monsanto Co in Q2 2014, selling an estimated $38M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 13% of its $14.4B portfolio in Q2 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 161 new positions and closed 120 in Q2 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 0.12% quarter-over-quarter to $14.4B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2014, filed 31 Jul 2014.